Contact
searchSearch
HMP Global

The Dermatologist

Featured

News
Machine Learning Identifies Potential Dual-Target Compounds for Atopic Dermatitis
05/05/2026
Jessica Garlewicz
Machine learning–based modeling may accelerate the discovery of novel therapies for atopic dermatitis by identifying compounds that simultaneously activate key anti-inflammatory pathways.
Machine learning–based modeling may accelerate the discovery of novel therapies for atopic dermatitis by identifying compounds that simultaneously activate key anti-inflammatory pathways.
Machine learning–based modeling...
05/05/2026
The Dermatologist
News
Cutaneous Pain in Atopic Dermatitis Linked to Higher Psychological Burden
05/05/2026
Jessica Garlewicz
Cutaneous pain in atopic dermatitis is strongly associated with increased anxiety, depression, stigmatization, and impaired quality of life.
Cutaneous pain in atopic dermatitis is strongly associated with increased anxiety, depression, stigmatization, and impaired quality of life.
Cutaneous pain in atopic...
05/05/2026
The Dermatologist
News
POEM Scores Align With Clinical Severity and Treatment Intensity in Pediatric Atopic Dermatitis
05/05/2026
Jessica Garlewicz
The Patient-Oriented Eczema Measure (POEM) may provide a practical and reliable assessment of disease severity in pediatric atopic dermatitis.
The Patient-Oriented Eczema Measure (POEM) may provide a practical and reliable assessment of disease severity in pediatric atopic dermatitis.
The Patient-Oriented Eczema...
05/05/2026
The Dermatologist
News
New Visual Scale Aims to Standardize Nail Psoriasis Severity Assessment
05/05/2026
Jessica Garlewicz
A newly developed visual tool may improve consistency in assessing fingernail psoriasis severity, addressing a longstanding gap in clinical trials and practice.
A newly developed visual tool may improve consistency in assessing fingernail psoriasis severity, addressing a longstanding gap in clinical trials and practice.
A newly developed visual tool...
05/05/2026
The Dermatologist
News
Macrophage-Focused Psoriasis Research Shifts Toward Precision Therapeutics
05/05/2026
Jessica Garlewicz
Research on macrophages in psoriasis has expanded over the past decade, with increasing emphasis on translational applications and precision medicine, according to a bibliometric analysis of global scientific output.
Research on macrophages in psoriasis has expanded over the past decade, with increasing emphasis on translational applications and precision medicine, according to a bibliometric analysis of global scientific output.
Research on macrophages in...
05/05/2026
The Dermatologist
News
Lifestyle and Behavioral Interventions Show Adjunctive Potential in Psoriasis Management
05/05/2026
Jessica Garlewicz
Non-pharmacological interventions, including diet, exercise, and psychological support, may offer complementary benefits in psoriasis management, although evidence remains heterogeneous and insufficient to replace standard therapy.
Non-pharmacological interventions, including diet, exercise, and psychological support, may offer complementary benefits in psoriasis management, although evidence remains heterogeneous and insufficient to replace standard therapy.
Non-pharmacological...
05/05/2026
The Dermatologist
News
IL23R Variant Shows Protective Association in Psoriasis Susceptibility Study
05/05/2026
Jessica Garlewicz
A genetic variant in the IL23R gene may confer protection against psoriasis in an Eastern European population, reinforcing the central role of the IL-23/Th17 pathway in disease pathogenesis.
A genetic variant in the IL23R gene may confer protection against psoriasis in an Eastern European population, reinforcing the central role of the IL-23/Th17 pathway in disease pathogenesis.
A genetic variant in the IL23R...
05/05/2026
The Dermatologist
Raj Chovatiya
Videos
Prurigo Nodularis: When Type 2 Inflammation Meets Neural Sensitization
05/01/2026
Raj Chovatiya, MD, PhD; Riya Gandhi, MA
Dr Raj Chovatiya explores the neuroimmune mechanisms driving prurigo nodularis, highlighting the role of type 2 inflammation, IL-31–mediated itch signaling, and cytokines like IL-4 and IL-13 in fibrosis and neuronal sensitization.
Dr Raj Chovatiya explores the neuroimmune mechanisms driving prurigo nodularis, highlighting the role of type 2 inflammation, IL-31–mediated itch signaling, and cytokines like IL-4 and IL-13 in fibrosis and neuronal sensitization.
Dr Raj Chovatiya explores the...
05/01/2026
The Dermatologist
Hair loss
News
Oral VDPHL01 Delivers Rapid, Robust Hair Growth in Phase 2/3 Trial for Male Pattern Hair Loss
04/28/2026
Riya Gandhi, MA
Extended-release oral minoxidil formulation achieves significant hair count increases and early clinical response with favorable safety.
Extended-release oral minoxidil formulation achieves significant hair count increases and early clinical response with favorable safety.
Extended-release oral minoxidil...
04/28/2026
The Dermatologist
Adam Sutton, MD, MBA
Videos
Recap: Surgical Reconstruction Planning for Optimal Outcomes
04/27/2026
Riya Gandhi, MA
Discover how Dr Adam Sutton approaches complex skin cancer reconstructions.
Discover how Dr Adam Sutton approaches complex skin cancer reconstructions.
Discover how Dr Adam Sutton...
04/27/2026
The Dermatologist
Omar Ibrahimi
Q&A
Scar Revision Strategies: When to Intervene and the Role of Laser Therapy
04/27/2026
Omar A. Ibrahimi, MD, PhD; Riya Gandhi, MA
This expert Q&A explores when scar revision is warranted, from functional impairment to patient-driven concerns.
This expert Q&A explores when scar revision is warranted, from functional impairment to patient-driven concerns.
This expert Q&A explores when...
04/27/2026
The Dermatologist

From The Issue

Derm Dx
What Caused This Truncal Rash?
04/07/2026
George G. Papadeas, BS; Nicolia S. Christy, PA-C; Aamir N. Hussain, MD, MAPP
A 16-year-old African American adolescent boy with no known past medical history presented with a dark eruption involving the chest and abdomen ongoing for 1 year.
A 16-year-old African American adolescent boy with no known past medical history presented with a dark eruption involving the chest and abdomen ongoing for 1 year.
A 16-year-old African American...
04/07/2026
The Dermatologist
Cover Story
Evolution of Aesthetics in Dermatology
04/06/2026
Michael H. Gold, MD, FAAD; Brian S. Biesman, MD, FACS; Riya Gandhi, MA
As aesthetic and medical dermatology continue to converge, the therapeutic toolbox has never been more expansive. Join Drs Gold and Biesman in uncovering the latest developments.
As aesthetic and medical dermatology continue to converge, the therapeutic toolbox has never been more expansive. Join Drs Gold and Biesman in uncovering the latest developments.
As aesthetic and medical...
04/06/2026
The Dermatologist
Clinical Tips
Improving New Treatment Adherence
04/06/2026
Benjamin Barankin, MD, FRCPC
Keep these tips in mind for your next appointment!
Keep these tips in mind for your next appointment!
Keep these tips in mind for your...
04/06/2026
The Dermatologist
Cover Story
More Than Cosmetic: Reframing Hyperpigmentation as a Clinical and Psychosocial Priority
03/09/2026
Oyetewa Boluwatito Asempa, MD, FAAD; Coleen Stern, MA; Riya Gandhi, MA
Dr Oyetewa Asempa explores the clinical, psychosocial, and equity-driven imperatives reshaping how dermatologists diagnose and treat hyperpigmentation disorders in patients with skin of color.
Dr Oyetewa Asempa explores the clinical, psychosocial, and equity-driven imperatives reshaping how dermatologists diagnose and treat hyperpigmentation disorders in patients with skin of color.
Dr Oyetewa Asempa explores the...
03/09/2026
The Dermatologist
Feature Story
Biosimilars in Dermatology: What Clinicians Need to Know in 2026
03/09/2026
Omar Raheel, BA; Jade Bajic, BSc; Ryan Hirsh, BS; Steven R. Feldman, MD, PhD
Get the answers to key questions about biosimilars, including what they are, how they are regulated, and how they affect prescribing, insurance coverage, and patient care.
Get the answers to key questions about biosimilars, including what they are, how they are regulated, and how they affect prescribing, insurance coverage, and patient care.
Get the answers to key questions...
03/09/2026
The Dermatologist
Feature Story
Beyond the Gut: Recognizing and Managing Inflammatory Bowel Disease in Dermatologic Practice
03/09/2026
David Fudman, MD; Riya Gandhi, MA
Gastroenterologist Dr David Fudman examines our evolving understanding of the gut-skin axis and the pivotal role dermatologists play in identifying and comanaging the cutaneous symptoms of luminal disease.
Gastroenterologist Dr David Fudman examines our evolving understanding of the gut-skin axis and the pivotal role dermatologists play in identifying and comanaging the cutaneous symptoms of luminal disease.
Gastroenterologist Dr David...
03/09/2026
The Dermatologist
Derm Dx
What Is This Persistent Scaly Plaque in the Axilla?
03/09/2026
Aamir N. Hussain, MD, MAPP; Umayr R. Shaikh, MPH; Kabir Al-Tariq, MS; David Terrano, MD, PhD
A 55-year-old woman with a history of hypertension and nonalcoholic fatty liver disease presented with a pruritic rash localized to her right axilla for 2 months.
A 55-year-old woman with a history of hypertension and nonalcoholic fatty liver disease presented with a pruritic rash localized to her right axilla for 2 months.
A 55-year-old woman with a...
03/09/2026
The Dermatologist
HSF-Reviewed Content
From Reactive to Proactive: Building Longitudinal Care Plans That Actually Work for Hidradenitis Suppurativa
03/09/2026
Mondana Ghias, MD, FAAD
Through a longitudinal approach, care teams can achieve greater clarity, stability, and long-term disease control.
Through a longitudinal approach, care teams can achieve greater clarity, stability, and long-term disease control.
Through a longitudinal approach,...
03/09/2026
The Dermatologist
Clinical Tips
The “Email Yourself” Reflection Habit
03/09/2026
Benjamin Barankin, MD, FRCPC
Keep these tips and pearls from dermatologic experts in mind for your next appointment.
Keep these tips and pearls from dermatologic experts in mind for your next appointment.
Keep these tips and pearls from...
03/09/2026
The Dermatologist
Derm Dx
What Caused These Changes on the Shins?
01/30/2026
Bruh Alem, MD; Aklilu Melaku, MD; Amor Khachemoune, MD, FAAD, FACMS
A 72-year-old man with a history of type 2 diabetes, obesity, and hypertension presented with multiple firm, well-circumscribed, reddish-brown, cystic lesions on both shins but more pronounced on his right shin.
A 72-year-old man with a history of type 2 diabetes, obesity, and hypertension presented with multiple firm, well-circumscribed, reddish-brown, cystic lesions on both shins but more pronounced on his right shin.
A 72-year-old man with a history...
01/30/2026
The Dermatologist

Multimedia

Raj Chovatiya
Videos
Prurigo Nodularis: When Type 2 Inflammation Meets Neural Sensitization
05/01/2026
Raj Chovatiya, MD, PhD; Riya Gandhi, MA
Dr Raj Chovatiya explores the neuroimmune mechanisms driving prurigo nodularis, highlighting the role of type 2 inflammation, IL-31–mediated itch signaling, and cytokines like IL-4 and IL-13 in fibrosis and neuronal sensitization.
Dr Raj Chovatiya explores the neuroimmune mechanisms driving prurigo nodularis, highlighting the role of type 2 inflammation, IL-31–mediated itch signaling, and cytokines like IL-4 and IL-13 in fibrosis and neuronal sensitization.
Dr Raj Chovatiya explores the...
05/01/2026
The Dermatologist
Adam Sutton, MD, MBA
Videos
Recap: Surgical Reconstruction Planning for Optimal Outcomes
04/27/2026
Riya Gandhi, MA
Discover how Dr Adam Sutton approaches complex skin cancer reconstructions.
Discover how Dr Adam Sutton approaches complex skin cancer reconstructions.
Discover how Dr Adam Sutton...
04/27/2026
The Dermatologist
John Zampella, MD, FAAD
Videos
Considerations for Treatment Decision-Making
04/16/2026
Shehla Admani, MD; Michael J. Payette, MD, MBA, FAAD; Melodie Young, MSN, GNP; John Zampella, MD, FAAD
This session explores evidence-based approaches to treatment selection for genital and intertriginous psoriasis, emphasizing the role of nonsteroidal and systemic therapies. Learn how shared decision-making and patient-centered goal setting...
This session explores evidence-based approaches to treatment selection for genital and intertriginous psoriasis, emphasizing the role of nonsteroidal and systemic therapies. Learn how shared decision-making and patient-centered goal setting...
This session explores...
04/16/2026
The Dermatologist
Michael Payette, MD, MBA, FAAD
Videos
Impact on Patient Quality of Life and Interpersonal Relationships
04/16/2026
Shehla Admani, MD; Michael J. Payette, MD, MBA, FAAD; Melodie Young, MSN, GNP; John Zampella, MD, FAAD
Experts examine the multidimensional burden of genital and intertriginous psoriasis, including effects on intimacy, daily functioning, and psychological well-being. Gain insight into the clinical consequences of delayed diagnosis and the...
Experts examine the multidimensional burden of genital and intertriginous psoriasis, including effects on intimacy, daily functioning, and psychological well-being. Gain insight into the clinical consequences of delayed diagnosis and the...
Experts examine the...
04/16/2026
The Dermatologist
Shehla Admani, MD
Videos
Diagnosis and Clinician–Patient Conversations
04/16/2026
Shehla Admani, MD; Michael J. Payette, MD, MBA, FAAD; Melodie Young, MSN, GNP; John Zampella, MD, FAAD
This discussion outlines best practices for the physical diagnosis of genital and intertriginous psoriasis, including the role of comprehensive skin examinations and considerations for biopsy in cases of diagnostic uncertainty. Experts also...
This discussion outlines best practices for the physical diagnosis of genital and intertriginous psoriasis, including the role of comprehensive skin examinations and considerations for biopsy in cases of diagnostic uncertainty. Experts also...
This discussion outlines best...
04/16/2026
The Dermatologist
Melodie Young, MSN A/GNP-c
Videos
Treatment Landscape and Unmet Needs
04/16/2026
Shehla Admani, MD; Michael J. Payette, MD, MBA, FAAD; Melodie Young, MSN, GNP; John Zampella, MD, FAAD
An expert panel reviews the current evidence landscape for genital and intertriginous psoriasis, highlighting gaps in epidemiology, clinical guidance, and standardized classification that contribute to variability in care. Learn how...
An expert panel reviews the current evidence landscape for genital and intertriginous psoriasis, highlighting gaps in epidemiology, clinical guidance, and standardized classification that contribute to variability in care. Learn how...
An expert panel reviews the...
04/16/2026
The Dermatologist
Heberton
Videos
Managing EGFR Skin Toxicities
04/01/2026
Riya Gandhi, MA
This interview focuses on the most common EGFR inhibitor–associated skin adverse events, when they typically emerge, and practical strategies to reduce severity—including skincare routines, photoprotection, and prophylactic approaches.
This interview focuses on the most common EGFR inhibitor–associated skin adverse events, when they typically emerge, and practical strategies to reduce severity—including skincare routines, photoprotection, and prophylactic approaches.
This interview focuses on the...
04/01/2026
The Dermatologist
Amy paller
Videos
Disease Biology and Early Recognition in Atopic Dermatitis
04/01/2026
Amy S. Paller, MD, MS; Riya Gandhi, MA
Dr Amy Paller discusses how recognizing pediatric atopic dermatitis as a type 2 inflammatory disease has transformed early treatment strategies, enabling safer and more proactive use of targeted therapies.
Dr Amy Paller discusses how recognizing pediatric atopic dermatitis as a type 2 inflammatory disease has transformed early treatment strategies, enabling safer and more proactive use of targeted therapies.
Dr Amy Paller discusses how...
04/01/2026
The Dermatologist
Joseph F. Merola, MD, MMSc, and Colby Evans, MD
Videos
Autoimmune Serologies in Dermatology
04/01/2026
Riya Gandhi, MA
Dr Joseph Merola breaks down how dermatologists can accurately interpret autoimmune serologies, with a focus on ANA testing, clinical context, and avoiding unnecessary labs.
Dr Joseph Merola breaks down how dermatologists can accurately interpret autoimmune serologies, with a focus on ANA testing, clinical context, and avoiding unnecessary labs.
Dr Joseph Merola breaks down how...
04/01/2026
The Dermatologist
Melissa Mauskar, MD
Videos
Practical Pearls of Vulvar Dermatoses
04/01/2026
Riya Gandhi, MA
Dr Melissa Mauskar discusses common diagnostic pitfalls in vulvar dermatoses, including overlapping conditions and misdiagnosis of lichen sclerosus versus genitourinary syndrome of menopause.
Dr Melissa Mauskar discusses common diagnostic pitfalls in vulvar dermatoses, including overlapping conditions and misdiagnosis of lichen sclerosus versus genitourinary syndrome of menopause.
Dr Melissa Mauskar discusses...
04/01/2026
The Dermatologist

Partner Reviewed

NRS Approved Features
Artificial Intelligence for Rosacea Diagnosis Shows Both Promise and Shortcomings
04/06/2026
Eden Robins
Recent studies point to the potential of using artificial intelligence models to diagnose dermatologic conditions while noting that the current state of these tools may lead to misdiagnosis, inaccurate information, and inaccessible language.
Recent studies point to the potential of using artificial intelligence models to diagnose dermatologic conditions while noting that the current state of these tools may lead to misdiagnosis, inaccurate information, and inaccessible language.
Recent studies point to the...
04/06/2026
The Dermatologist
NEA Approved Features
Supporting the Transition to Self-Managed Care in Adolescents and Young Adults With Atopic Dermatitis
03/09/2026
Allison Loiselle, PhD; Jessica Garlewicz
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association...
03/09/2026
The Dermatologist
NRS Approved Features
Do Fungi Play a Role in Rosacea?
01/30/2026
Andrew Huff
Imbalances in the mycobiome may contribute to the development of this chronic skin condition.
Imbalances in the mycobiome may contribute to the development of this chronic skin condition.
Imbalances in the mycobiome may...
01/30/2026
The Dermatologist
NPF Endorsed Features
Position Statement: Routine TB Testing for IL-17 and IL-23 Inhibitors
01/30/2026
Lisa Kuhns, PhD, MD
A new NPF Medical Board/International Psoriasis Council joint position statement concludes that routine latent tuberculosis infection testing is unnecessary for patients with psoriasis who are taking IL-17 or IL-23 inhibitors.
A new NPF Medical Board/International Psoriasis Council joint position statement concludes that routine latent tuberculosis infection testing is unnecessary for patients with psoriasis who are taking IL-17 or IL-23 inhibitors.
A new NPF Medical...
01/30/2026
The Dermatologist
NAAF-Reviewed Content
Managing Alopecia Areata With JAK Inhibitors: Timing, Response, and Long-Term Strategy
01/30/2026
Brett A. King, MD, PhD
As JAK inhibitors reshape the treatment landscape for alopecia areata, clinicians face new questions about when to initiate treatment, therapeutic expectations, and management over time.
As JAK inhibitors reshape the treatment landscape for alopecia areata, clinicians face new questions about when to initiate treatment, therapeutic expectations, and management over time.
As JAK inhibitors reshape the...
01/30/2026
The Dermatologist
NEA Approved Features
Patient Self-Monitoring and Shared Decision-Making in Atopic Dermatitis
12/09/2025
Jessica Garlewicz
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to...
12/09/2025
The Dermatologist
NAAF-Reviewed Content
Psychosocial Impact of Alopecia Areata in Pediatric Populations
10/06/2025
Riya Gandhi, MA
Integrating mental health assessment and support into our management of this disease in children and adolescents is imperative to ensure positive quality of life outcomes.
Integrating mental health assessment and support into our management of this disease in children and adolescents is imperative to ensure positive quality of life outcomes.
Integrating mental health...
10/06/2025
The Dermatologist
NPF Endorsed Features
Psoriatic Disease and the Domino Effect of Comorbidities
10/06/2025
Lisa Kuhns, PhD, MD
Research has consistently shown that people with psoriasis and psoriatic arthritis face higher rates of serious comorbidities
Research has consistently shown that people with psoriasis and psoriatic arthritis face higher rates of serious comorbidities
Research has consistently shown...
10/06/2025
The Dermatologist
NRS Approved Features
New Study Finds Skin Microbiome Differences Between Rosacea and Similar Conditions
10/06/2025
Andrew Huff
The community of microorganisms present on our skin may play an important role in the development of steroid-induced rosacea and perioral dermatitis.
The community of microorganisms present on our skin may play an important role in the development of steroid-induced rosacea and perioral dermatitis.
The community of microorganisms...
10/06/2025
The Dermatologist
Cover Story
Janus Kinase Inhibitors and Alopecia Areata: From Data to Dialogue
09/08/2025
Justin M. Ko, MD, MBA
Dr Justin Ko shares patient-centered strategies for discussing boxed warnings, risk assessment, and therapeutic goals.
Dr Justin Ko shares patient-centered strategies for discussing boxed warnings, risk assessment, and therapeutic goals.
Dr Justin Ko shares...
09/08/2025
The Dermatologist

News and FDA Alerts

News
Machine Learning Identifies Potential Dual-Target Compounds for Atopic Dermatitis
05/05/2026
Jessica Garlewicz
Machine learning–based modeling may accelerate the discovery of novel therapies for atopic dermatitis by identifying compounds that simultaneously activate key anti-inflammatory pathways.
Machine learning–based modeling may accelerate the discovery of novel therapies for atopic dermatitis by identifying compounds that simultaneously activate key anti-inflammatory pathways.
Machine learning–based modeling...
05/05/2026
The Dermatologist
News
Cutaneous Pain in Atopic Dermatitis Linked to Higher Psychological Burden
05/05/2026
Jessica Garlewicz
Cutaneous pain in atopic dermatitis is strongly associated with increased anxiety, depression, stigmatization, and impaired quality of life.
Cutaneous pain in atopic dermatitis is strongly associated with increased anxiety, depression, stigmatization, and impaired quality of life.
Cutaneous pain in atopic...
05/05/2026
The Dermatologist
News
POEM Scores Align With Clinical Severity and Treatment Intensity in Pediatric Atopic Dermatitis
05/05/2026
Jessica Garlewicz
The Patient-Oriented Eczema Measure (POEM) may provide a practical and reliable assessment of disease severity in pediatric atopic dermatitis.
The Patient-Oriented Eczema Measure (POEM) may provide a practical and reliable assessment of disease severity in pediatric atopic dermatitis.
The Patient-Oriented Eczema...
05/05/2026
The Dermatologist
News
New Visual Scale Aims to Standardize Nail Psoriasis Severity Assessment
05/05/2026
Jessica Garlewicz
A newly developed visual tool may improve consistency in assessing fingernail psoriasis severity, addressing a longstanding gap in clinical trials and practice.
A newly developed visual tool may improve consistency in assessing fingernail psoriasis severity, addressing a longstanding gap in clinical trials and practice.
A newly developed visual tool...
05/05/2026
The Dermatologist
News
Macrophage-Focused Psoriasis Research Shifts Toward Precision Therapeutics
05/05/2026
Jessica Garlewicz
Research on macrophages in psoriasis has expanded over the past decade, with increasing emphasis on translational applications and precision medicine, according to a bibliometric analysis of global scientific output.
Research on macrophages in psoriasis has expanded over the past decade, with increasing emphasis on translational applications and precision medicine, according to a bibliometric analysis of global scientific output.
Research on macrophages in...
05/05/2026
The Dermatologist
News
Lifestyle and Behavioral Interventions Show Adjunctive Potential in Psoriasis Management
05/05/2026
Jessica Garlewicz
Non-pharmacological interventions, including diet, exercise, and psychological support, may offer complementary benefits in psoriasis management, although evidence remains heterogeneous and insufficient to replace standard therapy.
Non-pharmacological interventions, including diet, exercise, and psychological support, may offer complementary benefits in psoriasis management, although evidence remains heterogeneous and insufficient to replace standard therapy.
Non-pharmacological...
05/05/2026
The Dermatologist
News
IL23R Variant Shows Protective Association in Psoriasis Susceptibility Study
05/05/2026
Jessica Garlewicz
A genetic variant in the IL23R gene may confer protection against psoriasis in an Eastern European population, reinforcing the central role of the IL-23/Th17 pathway in disease pathogenesis.
A genetic variant in the IL23R gene may confer protection against psoriasis in an Eastern European population, reinforcing the central role of the IL-23/Th17 pathway in disease pathogenesis.
A genetic variant in the IL23R...
05/05/2026
The Dermatologist
Hair loss
News
Oral VDPHL01 Delivers Rapid, Robust Hair Growth in Phase 2/3 Trial for Male Pattern Hair Loss
04/28/2026
Riya Gandhi, MA
Extended-release oral minoxidil formulation achieves significant hair count increases and early clinical response with favorable safety.
Extended-release oral minoxidil formulation achieves significant hair count increases and early clinical response with favorable safety.
Extended-release oral minoxidil...
04/28/2026
The Dermatologist
News
Oral Icotrokinra Shows Strong Short-Term Efficacy in Plaque Psoriasis, Meta-Analysis Finds
04/07/2026
Jessica Garlewicz
Oral icotrokinra, a selective interleukin-23 receptor antagonist, demonstrated significant improvements in skin clearance and patient-reported outcomes in moderate-to-severe plaque psoriasis.
Oral icotrokinra, a selective interleukin-23 receptor antagonist, demonstrated significant improvements in skin clearance and patient-reported outcomes in moderate-to-severe plaque psoriasis.
Oral icotrokinra, a selective...
04/07/2026
The Dermatologist
News
Updated Review Highlights Diagnostic Tools and Treatment Strategies for Scalp Psoriasis
04/07/2026
Jessica Garlewicz
Scalp psoriasis, affecting up to 80% of patients with psoriasis, remains a common and often difficult-to-treat manifestation.
Scalp psoriasis, affecting up to 80% of patients with psoriasis, remains a common and often difficult-to-treat manifestation.
Scalp psoriasis, affecting up to...
04/07/2026
The Dermatologist

Quizzes and Polls

Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist

Professional Development

Dr Adam Friedman
Podcasts
The Real Derm: Episode 5, Diving Deep Into the DermPath Pathway: A Candidate's Perspective
07/10/2025
Adam Friedman, MD
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to...
07/10/2025
The Dermatologist
Dr. Adam Friedman and Jaya Manjunath
Podcasts
The Elderderm: Episode 4, Combatting Barriers to Care For Elder Patients
10/16/2024
Adam Friedman, MD
Collaboration and consideration are key to a successful medical intervention.
Collaboration and consideration are key to a successful medical intervention.
Collaboration and consideration...
10/16/2024
The Dermatologist
The ElderDerm: Episode 3, Shared- Decision Making
Podcasts
The ElderDerm: Episode 3, Shared-Decision Making
05/16/2024
Adam Friedman, MD; Jaya Manjunath
In our next segment of the ElderDerm Podcast, listen to co-hosts Dr Adam Friedman and Jaya Manjunath discuss what shared decision-making is, and why it is important in dermatology.
In our next segment of the ElderDerm Podcast, listen to co-hosts Dr Adam Friedman and Jaya Manjunath discuss what shared decision-making is, and why it is important in dermatology.
In our next segment of the...
05/16/2024
The Dermatologist
Aging and Geriatric Evaluation in Dermatology
Podcasts
The ElderDerm: Episode 2, Aging and Geriatric Evaluation in Dermatology
04/22/2024
Adam Friedman, MD; Jaya Manjunath
In this episode of the ElderDerm Podcast, co-hosts Dr Adam Friedman and Jaya Manjunath discuss the Aging and Geriatric Evaluation in Dermatology (AGED) workgroup.
In this episode of the ElderDerm Podcast, co-hosts Dr Adam Friedman and Jaya Manjunath discuss the Aging and Geriatric Evaluation in Dermatology (AGED) workgroup.
In this episode of the ElderDerm...
04/22/2024
The Dermatologist
ElderDerm
Podcasts
The ElderDerm: Episode 1, Geriatric Dermatology
01/29/2024
Jaya Manjunath; Adam Friedman, MD
Listen to the first ElderDerm Podcast, where co-hosts Dr Adam Friedman and Jaya Manjunath discuss what is geriatric dermatology, and why there is a need for this area in training.
Listen to the first ElderDerm Podcast, where co-hosts Dr Adam Friedman and Jaya Manjunath discuss what is geriatric dermatology, and why there is a need for this area in training.
Listen to the first ElderDerm...
01/29/2024
The Dermatologist

Conference Coverage

wells
Clinical Insights
Addressing Unmet Needs in Psoriatic Arthritis: Diagnosis, Pathogenesis, and Newer/Emerging Oral Therapies
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dr Wells delivered a forward-thinking discussion on psoriatic arthritis, emphasizing that up to 30% of patients with psoriasis develop PsA and reinforcing that psoriasis is a systemic inflammatory.
Dr Wells delivered a forward-thinking discussion on psoriatic arthritis, emphasizing that up to 30% of patients with psoriasis develop PsA and reinforcing that psoriasis is a systemic inflammatory.
Dr Wells delivered a...
03/02/2026
The Dermatologist
Blauvelt
Clinical Insights
Transforming Psoriasis Care: Oral IL-23 Therapy and the Next Frontier in Patient-Centered Treatment
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dr Blauvelt emphasized that psoriasis should be approached as a whole-person disease, one that affects mental health and is associated with systemic comorbidities.
Dr Blauvelt emphasized that psoriasis should be approached as a whole-person disease, one that affects mental health and is associated with systemic comorbidities.
Dr Blauvelt emphasized that...
03/02/2026
The Dermatologist
Werth
Clinical Insights
Advances in Dermatomyositis: The Evolving Landscape and Potential Role of Novel Therapies to Improve Disease Outcomes
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dermatomyositis is a systemic autoimmune myopathy with prominent cutaneous features and significant heterogeneity across organ involvement, autoantibody profiles, and disease course.
Dermatomyositis is a systemic autoimmune myopathy with prominent cutaneous features and significant heterogeneity across organ involvement, autoantibody profiles, and disease course.
Dermatomyositis is a systemic...
03/02/2026
The Dermatologist
Gottlieb
Clinical Insights
Reimagining Hidradenitis Suppurativa Care: Early Recognition, Therapeutic Innovation, and Multidisciplinary Care Across the Patient Journey
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
During an expert discussion, speakers emphasized that improving outcomes in HS requires earlier recognition, reduction of diagnostic delay, coordinated referral systems, and integration of medical and surgical management.
During an expert discussion, speakers emphasized that improving outcomes in HS requires earlier recognition, reduction of diagnostic delay, coordinated referral systems, and integration of medical and surgical management.
During an expert discussion,...
03/02/2026
The Dermatologist
Asempa
Clinical Insights
Advancing Inclusive Outcome Measures in Dermatology
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
In a recent panel discussion, Dr Asempa and Dr Alexis emphasized that without inclusive trial design and culturally responsive terminology, we risk biased severity assessments and inequitable treatment decisions.
In a recent panel discussion, Dr Asempa and Dr Alexis emphasized that without inclusive trial design and culturally responsive terminology, we risk biased severity assessments and inequitable treatment decisions.
In a recent panel discussion, Dr...
03/02/2026
The Dermatologist
Krueger
Clinical Insights
Advancing Oral Therapies in Psoriasis: Targeted Innovation for Improved Disease Control and Patient Adherence
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
At a recent session led by Dr Krueger and Dr Glick, evolving strategies for evaluating and treating moderate-to-severe psoriasis were highlighted, with particular attention to high-impact areas.
At a recent session led by Dr Krueger and Dr Glick, evolving strategies for evaluating and treating moderate-to-severe psoriasis were highlighted, with particular attention to high-impact areas.
At a recent session led by Dr...
03/02/2026
The Dermatologist
Yosipovitch
Clinical Insights
Rapid Neuromodulation and Mast Cell Targeting in Chronic Pruritus
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dr Yosipovitch emphasized that effective itch management requires directly targeting neuronal signaling pathways and mast cell activation, particularly in itch-dominant diseases such as prurigo nodularis.
Dr Yosipovitch emphasized that effective itch management requires directly targeting neuronal signaling pathways and mast cell activation, particularly in itch-dominant diseases such as prurigo nodularis.
Dr Yosipovitch emphasized that...
03/02/2026
The Dermatologist
Yoo
Clinical Insights
Ultrasound as a Transformative Tool in Dermatology: From Cosmetic Imaging to Hidradenitis Suppurativa Assessment and Emerging Therapies
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dr Yoo and Dr Gottlieb reviewed the principles and applications of handheld ultrasound devices, sonographic assessment of hidradenitis suppurativa, aesthetic procedure guidance, and the expanding landscape of HS therapeutics.
Dr Yoo and Dr Gottlieb reviewed the principles and applications of handheld ultrasound devices, sonographic assessment of hidradenitis suppurativa, aesthetic procedure guidance, and the expanding landscape of HS therapeutics.
Dr Yoo and Dr Gottlieb reviewed...
03/02/2026
The Dermatologist
Dr Heberton
Conference Coverage
Checkpoint Inhibitor Rashes: When to Treat, When to Rechallenge, and When It’s Not the Drug
02/22/2026
Riya Gandhi, MA
A clinical update on cutaneous immune-related adverse events from PD-1/PD-L1 inhibitors, covering lichenoid eruptions, psoriasis, bullous pemphigoid, dupilumab, steroid-sparing strategies, and immune checkpoint inhibitor rechallenge.
A clinical update on cutaneous immune-related adverse events from PD-1/PD-L1 inhibitors, covering lichenoid eruptions, psoriasis, bullous pemphigoid, dupilumab, steroid-sparing strategies, and immune checkpoint inhibitor rechallenge.
A clinical update on cutaneous...
02/22/2026
The Dermatologist
Dr Heberton
Conference Coverage
EGFR Inhibitor Rashes: Prophylaxis, Isotretinoin, and When to Culture
02/22/2026
Riya Gandhi, MA
A clinical update on cutaneous toxicities of epidermal growth factor receptor inhibitors, covering acneiform eruptions, paronychia, staphylococcal superinfection, xerosis, isotretinoin use, and amivantamab-specific toxicities.
A clinical update on cutaneous toxicities of epidermal growth factor receptor inhibitors, covering acneiform eruptions, paronychia, staphylococcal superinfection, xerosis, isotretinoin use, and amivantamab-specific toxicities.
A clinical update on cutaneous...
02/22/2026
The Dermatologist

Popular Articles

acne
News
Evolution of Acne Research Based on Top-Cited Articles
05/29/2024
Jessica Garlewicz
Researchers conducted a comprehensive search of the Web of Science database on August 8, 2023.
Researchers conducted a comprehensive search of the Web of Science database on August 8, 2023.
Researchers conducted a...
05/29/2024
The Dermatologist
telemedicine
News
Dupilumab Demonstrates Efficacy Across All Levels of Prurigo Nodularis Severity: Combined Results from Phase 3 Trials
06/23/2024
Riya Gandhi, MA
In a comprehensive analysis pooling data from 2 pivotal phase 3 trials, researchers have shown that dupilumab effectively alleviates pruritus and reduces skin lesions in patients with prurigo nodularis, irrespective of the severity of their...
In a comprehensive analysis pooling data from 2 pivotal phase 3 trials, researchers have shown that dupilumab effectively alleviates pruritus and reduces skin lesions in patients with prurigo nodularis, irrespective of the severity of their...
In a comprehensive analysis...
06/23/2024
The Dermatologist
skin cancer
News
Skin Cancers Associated with Genodermatoses in Patients with Skin of Color
08/09/2024
Jessica Garlewicz
Researchers aimed to identify notable characteristics in location, frequency, and severity of cutaneous findings, along with the median age of skin cancers in patients with skin of color.
Researchers aimed to identify notable characteristics in location, frequency, and severity of cutaneous findings, along with the median age of skin cancers in patients with skin of color.
Researchers aimed to identify...
08/09/2024
The Dermatologist
Clinical Insights
Strategies for Managing Pediatric Atopic Dermatitis
10/07/2024
Riya Gandhi, MA
“The list of things that we can consider for our pediatric patients is growing by the month, and that is very exciting,” says Dr Lisa Swanson.
“The list of things that we can consider for our pediatric patients is growing by the month, and that is very exciting,” says Dr Lisa Swanson.
“The list of things that we can...
10/07/2024
The Dermatologist
Case Report
Treatment of Recurrent Erythema Multiforme in an Immunosuppressed Patient
05/06/2024
Steven R. Feldman, MD, PhD
We present a recurrent case of this acute, type IV hypersensitivity reaction with extensive cutaneous and oral involvement in a patient on infliximab despite standard antiherpetic treatment.
We present a recurrent case of this acute, type IV hypersensitivity reaction with extensive cutaneous and oral involvement in a patient on infliximab despite standard antiherpetic treatment.
We present a recurrent case of...
05/06/2024
The Dermatologist
April/May 2026 cover

Current Issue

May 2026
Volume 34
Issue 3
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use